Using the fragment molecular orbital method to investigate agonist–orexin-2 receptor interactions
Open Access
- 11 April 2016
- journal article
- Published by Portland Press Ltd. in Biochemical Society Transactions
- Vol. 44 (2), 574-581
- https://doi.org/10.1042/bst20150250
Abstract
The understanding of binding interactions between any protein and a small molecule plays a key role in the rationalization of affinity and selectivity and is essential for an efficient structure-based drug discovery (SBDD) process. Clearly, to begin SBDD, a structure is needed, and although there has been fantastic progress in solving G-protein-coupled receptor (GPCR) crystal structures, the process remains quite slow and is not currently feasible for every GPCR or GPCR–ligand complex. This situation significantly limits the ability of X-ray crystallography to impact the drug discovery process for GPCR targets in ‘real-time’ and hence there is still a need for other practical and cost-efficient alternatives. We present here an approach that integrates our previously described hierarchical GPCR modelling protocol (HGMP) and the fragment molecular orbital (FMO) quantum mechanics (QM) method to explore the interactions and selectivity of the human orexin-2 receptor (OX2R) and its recently discovered nonpeptidic agonists. HGMP generates a 3D model of GPCR structures and its complexes with small molecules by applying a set of computational methods. FMO allows ab initio approaches to be applied to systems that conventional QM methods would find challenging. The key advantage of FMO is that it can reveal information on the individual contribution and chemical nature of each residue and water molecule to the ligand binding that normally would be difficult to detect without QM. We illustrate how the combination of both techniques provides a practical and efficient approach that can be used to analyse the existing structure–function relationships (SAR) and to drive forward SBDD in a real-world example for which there is no crystal structure of the complex available.Keywords
This publication has 49 references indexed in Scilit:
- Thematic Minireview Series: New Directions in G Protein-coupled Receptor PharmacologyJournal of Biological Chemistry, 2015
- From G Protein-coupled Receptor Structure Resolution to Rational Drug DesignJournal of Biological Chemistry, 2015
- GPCR crystal structures: Medicinal chemistry in the pocketBioorganic & Medicinal Chemistry, 2015
- GPCR structure, function, drug discovery and crystallography: report from Academia-Industry International Conference (UK Royal Society) Chicheley Hall, 1–2 September 2014Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 2015
- GPCR structures in drug design, emerging opportunities with new structuresBioorganic & Medicinal Chemistry Letters, 2014
- The Druggable Genome: Evaluation of Drug Targets in Clinical Trials Suggests Major Shifts in Molecular Class and IndicationAnnual Review of Pharmacology and Toxicology, 2014
- The Interplay Between Molecular Modeling and Chemoinformatics to Characterize Protein–Ligand and Protein–Protein Interactions Landscapes for Drug DiscoveryPublished by Elsevier BV ,2014
- A Medicinal Chemist’s Guide to Molecular InteractionsJournal of Medicinal Chemistry, 2010
- How many drug targets are there?Nature Reviews Drug Discovery, 2006
- Target validation of G-protein coupled receptorsDrug Discovery Today, 2002